INJ Price Prediction: Targets $6.20 by February Despite Current Weakness

Injective (INJ) faces short-term pressure at $4.67 but analysts maintain $6.20 target within 4-6 weeks. Technical indicators show oversold conditions creating potential entry opportunity.